非侵襲グルコース監視装置のグローバル市場2023-2027:ウェアラブル型、非ウェアラブル型

【英語タイトル】Global Non-invasive Glucose Monitoring Devices Market 2023-2027

Technavioが出版した調査資料(IRTNTR70187-23)・商品コード:IRTNTR70187-23
・発行会社(調査会社):Technavio
・発行日:2023年1月25日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートでは、世界の非侵襲グルコース監視装置市場規模が2023年から2027年の間に22.49百万ドルに到達すると見込んでおり、予測期間中の年平均成長率は15.68%になると予想しています。本レポートでは、非侵襲グルコース監視装置の世界市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、製品別(ウェアラブル型、非ウェアラブル型)分析、エンドユーザー別(在宅医療、病院、クリニック)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、アメリカ、ドイツ、イギリス、インド、中国、その他地域)分析、企業分析など、以下の構成でまとめています。本レポートには、Abbott Laboratories、Ascensia Diabetes Care Holdings AG、BlueSemi、BoydSense SAS、Cnoga、Dexcom Inc.、DiaMonTech AG、Eser Co.、F. Hoffmann La Roche Ltd.、Gluco Rx Ltd.、GlucoTrack Inc.、Informed Data Systems Inc. and One Drop.、Medtronic Plc、Meta Materials Inc.、Nemaura Medical Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界の非侵襲グルコース監視装置市場規模:製品別
- ウェアラブル型非侵襲グルコース監視装置の市場規模
- 非ウェアラブル型非侵襲グルコース監視装置の市場規模
・世界の非侵襲グルコース監視装置市場規模:エンドユーザー別
- 在宅医療における市場規模
- 病院における市場規模
- クリニックにおける市場規模
・顧客状況
・世界の非侵襲グルコース監視装置市場規模:地域別
- 北米の非侵襲グルコース監視装置市場規模
- ヨーロッパの非侵襲グルコース監視装置市場規模
- アジアの非侵襲グルコース監視装置市場規模
- アメリカの非侵襲グルコース監視装置市場規模
- ドイツの非侵襲グルコース監視装置市場規模
- イギリスの非侵襲グルコース監視装置市場規模
- インドの非侵襲グルコース監視装置市場規模
- 中国の非侵襲グルコース監視装置市場規模
- その他地域の非侵襲グルコース監視装置市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、非侵襲グルコース監視装置市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な非侵襲グルコース監視装置市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

非侵襲グルコース監視装置の世界市場 2023-2027

Technavio社は、非侵襲グルコース監視装置市場をモニターしており、2022年から2027年にかけて22,49百万ドルの成長が予測され、予測期間中のCAGRは15.68%で加速すると予測しています。当レポートでは、非侵襲グルコース監視装置市場について、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析など、包括的な分析を提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、糖尿病の有病率の増加、政府プログラムの増加、製品の発売、非侵襲的手技の需要増加が牽引しています。

Technavio社の非侵襲グルコース監視装置市場は以下のように区分されます:

・製品別:
– ウェアラブル
– 非ウェアラブル

・エンドユーザー別:
– 在宅ケア環境
– 病院
– 診療所

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、今後数年間の非侵襲グルコース監視装置市場の成長を促進する主な理由の一つとして、事業拡大のための共同研究への注目の高まりを挙げています。また、グルコース監視におけるAIとレーダー技術の統合や、非侵襲的グルコースモニタリング技術への資金提供の増加は、市場の大きな需要につながるでしょう。

Technavio社は、主要パラメータの分析による複数の情報源からのデータの調査、合成、集計の方法により、市場の詳細な姿を提示します。

当レポートでは、非侵襲グルコース監視装置市場について、以下の分野をカバーしています:
– 非侵襲グルコース監視装置市場のサイジング
– 非侵襲グルコース監視装置市場予測
– 非侵襲グルコース監視装置市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., F. Hoffmann La Roche Ltd., Gluco Rx Ltd., GlucoTrack Inc., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Incなどの企業情報が含まれています。また、非侵襲グルコース監視装置市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global non-invasive glucose monitoring devices market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global non-invasive glucose monitoring devices market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 End-User Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Wearable – Market size and forecast 2022-2027
o Exhibit 34: Chart on Wearable – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Wearable – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Wearable – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Wearable – Year-over-year growth 2022-2027 (%)
o 6.4 Non-wearable – Market size and forecast 2022-2027
o Exhibit 38: Chart on Non-wearable – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Non-wearable – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Non-wearable – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Non-wearable – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Home care settings – Market size and forecast 2022-2027
o Exhibit 47: Chart on Home care settings – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Home care settings – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Home care settings – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Home care settings – Year-over-year growth 2022-2027 (%)
o 7.4 Hospitals – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.5 Clinics – Market size and forecast 2022-2027
o Exhibit 55: Chart on Clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Clinics – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 59: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 India – Market size and forecast 2022-2027
o Exhibit 93: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories – Overview
o Exhibit 109: Abbott Laboratories – Business segments
o Exhibit 110: Abbott Laboratories – Key news
o Exhibit 111: Abbott Laboratories – Key offerings
o Exhibit 112: Abbott Laboratories – Segment focus
o 12.4 Ascensia Diabetes Care Holdings AG
o Exhibit 113: Ascensia Diabetes Care Holdings AG – Overview
o Exhibit 114: Ascensia Diabetes Care Holdings AG – Product / Service
o Exhibit 115: Ascensia Diabetes Care Holdings AG – Key offerings
o 12.5 BoydSense SAS
o Exhibit 116: BoydSense SAS – Overview
o Exhibit 117: BoydSense SAS – Product / Service
o Exhibit 118: BoydSense SAS – Key offerings
o 12.6 Cnoga
o Exhibit 119: Cnoga – Overview
o Exhibit 120: Cnoga – Product / Service
o Exhibit 121: Cnoga – Key offerings
o 12.7 Dexcom Inc.
o Exhibit 122: Dexcom Inc. – Overview
o Exhibit 123: Dexcom Inc. – Product / Service
o Exhibit 124: Dexcom Inc. – Key news
o Exhibit 125: Dexcom Inc. – Key offerings
o 12.8 DiaMonTech AG
o Exhibit 126: DiaMonTech AG – Overview
o Exhibit 127: DiaMonTech AG – Product / Service
o Exhibit 128: DiaMonTech AG – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 129: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 130: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 131: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 132: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 133: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 GlucoTrack Inc.
o Exhibit 134: GlucoTrack Inc. – Overview
o Exhibit 135: GlucoTrack Inc. – Product / Service
o Exhibit 136: GlucoTrack Inc. – Key offerings
o 12.11 Medtronic Plc
o Exhibit 137: Medtronic Plc – Overview
o Exhibit 138: Medtronic Plc – Business segments
o Exhibit 139: Medtronic Plc – Key news
o Exhibit 140: Medtronic Plc – Key offerings
o Exhibit 141: Medtronic Plc – Segment focus
o 12.12 Meta Materials Inc.
o Exhibit 142: Meta Materials Inc. – Overview
o Exhibit 143: Meta Materials Inc. – Key offerings
o 12.13 Nemaura Medical Inc.
o Exhibit 144: Nemaura Medical Inc. – Overview
o Exhibit 145: Nemaura Medical Inc. – Product / Service
o Exhibit 146: Nemaura Medical Inc. – Key offerings
o 12.14 Platinum Equity Advisors LLC
o Exhibit 147: Platinum Equity Advisors LLC – Overview
o Exhibit 148: Platinum Equity Advisors LLC – Product / Service
o Exhibit 149: Platinum Equity Advisors LLC – Key offerings
o 12.15 Rite Aid Corp.
o Exhibit 150: Rite Aid Corp. – Overview
o Exhibit 151: Rite Aid Corp. – Key offerings
o 12.16 Taiwan Biophotonic Co.
o Exhibit 152: Taiwan Biophotonic Co. – Overview
o Exhibit 153: Taiwan Biophotonic Co. – Product / Service
o Exhibit 154: Taiwan Biophotonic Co. – Key offerings
o 12.17 Walgreens Boots Alliance Inc.
o Exhibit 155: Walgreens Boots Alliance Inc. – Overview
o Exhibit 156: Walgreens Boots Alliance Inc. – Business segments
o Exhibit 157: Walgreens Boots Alliance Inc. – Key offerings
o Exhibit 158: Walgreens Boots Alliance Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 159: Inclusions checklist
o Exhibit 160: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 161: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 162: Research methodology
o Exhibit 163: Validation techniques employed for market sizing
o Exhibit 164: Information sources
o 13.5 List of abbreviations
o Exhibit 165: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global non-invasive glucose monitoring devices market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Wearable – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Wearable – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Wearable – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Wearable – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-wearable – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-wearable – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-wearable – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-wearable – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on End-user – Market share 2022-2027 (%)
Exhibits44: Data Table on End-user – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Home care settings – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Home care settings – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Home care settings – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Home care settings – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Clinics – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Clinics – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Clinics – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Clinics – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories – Overview
Exhibits109: Abbott Laboratories – Business segments
Exhibits110: Abbott Laboratories – Key news
Exhibits111: Abbott Laboratories – Key offerings
Exhibits112: Abbott Laboratories – Segment focus
Exhibits113: Ascensia Diabetes Care Holdings AG – Overview
Exhibits114: Ascensia Diabetes Care Holdings AG – Product / Service
Exhibits115: Ascensia Diabetes Care Holdings AG – Key offerings
Exhibits116: BoydSense SAS – Overview
Exhibits117: BoydSense SAS – Product / Service
Exhibits118: BoydSense SAS – Key offerings
Exhibits119: Cnoga – Overview
Exhibits120: Cnoga – Product / Service
Exhibits121: Cnoga – Key offerings
Exhibits122: Dexcom Inc. – Overview
Exhibits123: Dexcom Inc. – Product / Service
Exhibits124: Dexcom Inc. – Key news
Exhibits125: Dexcom Inc. – Key offerings
Exhibits126: DiaMonTech AG – Overview
Exhibits127: DiaMonTech AG – Product / Service
Exhibits128: DiaMonTech AG – Key offerings
Exhibits129: F. Hoffmann La Roche Ltd. – Overview
Exhibits130: F. Hoffmann La Roche Ltd. – Business segments
Exhibits131: F. Hoffmann La Roche Ltd. – Key news
Exhibits132: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits134: GlucoTrack Inc. – Overview
Exhibits135: GlucoTrack Inc. – Product / Service
Exhibits136: GlucoTrack Inc. – Key offerings
Exhibits137: Medtronic Plc – Overview
Exhibits138: Medtronic Plc – Business segments
Exhibits139: Medtronic Plc – Key news
Exhibits140: Medtronic Plc – Key offerings
Exhibits141: Medtronic Plc – Segment focus
Exhibits142: Meta Materials Inc. – Overview
Exhibits143: Meta Materials Inc. – Key offerings
Exhibits144: Nemaura Medical Inc. – Overview
Exhibits145: Nemaura Medical Inc. – Product / Service
Exhibits146: Nemaura Medical Inc. – Key offerings
Exhibits147: Platinum Equity Advisors LLC – Overview
Exhibits148: Platinum Equity Advisors LLC – Product / Service
Exhibits149: Platinum Equity Advisors LLC – Key offerings
Exhibits150: Rite Aid Corp. – Overview
Exhibits151: Rite Aid Corp. – Key offerings
Exhibits152: Taiwan Biophotonic Co. – Overview
Exhibits153: Taiwan Biophotonic Co. – Product / Service
Exhibits154: Taiwan Biophotonic Co. – Key offerings
Exhibits155: Walgreens Boots Alliance Inc. – Overview
Exhibits156: Walgreens Boots Alliance Inc. – Business segments
Exhibits157: Walgreens Boots Alliance Inc. – Key offerings
Exhibits158: Walgreens Boots Alliance Inc. – Segment focus
Exhibits159: Inclusions checklist
Exhibits160: Exclusions checklist
Exhibits161: Currency conversion rates for US$
Exhibits162: Research methodology
Exhibits163: Validation techniques employed for market sizing
Exhibits164: Information sources
Exhibits165: List of abbreviations



★調査レポート[非侵襲グルコース監視装置のグローバル市場2023-2027:ウェアラブル型、非ウェアラブル型] (コード:IRTNTR70187-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[非侵襲グルコース監視装置のグローバル市場2023-2027:ウェアラブル型、非ウェアラブル型]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆